Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1754902rdf:typepubmed:Citationlld:pubmed
pubmed-article:1754902lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:1754902lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:1754902lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:1754902lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:1754902lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:1754902lifeskim:mentionsumls-concept:C0014792lld:lifeskim
pubmed-article:1754902lifeskim:mentionsumls-concept:C0003364lld:lifeskim
pubmed-article:1754902lifeskim:mentionsumls-concept:C0005823lld:lifeskim
pubmed-article:1754902lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1754902lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:1754902lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:1754902lifeskim:mentionsumls-concept:C0205224lld:lifeskim
pubmed-article:1754902lifeskim:mentionsumls-concept:C0857121lld:lifeskim
pubmed-article:1754902pubmed:issue4lld:pubmed
pubmed-article:1754902pubmed:dateCreated1992-1-27lld:pubmed
pubmed-article:1754902pubmed:abstractTextThe effects of antihypertensive factor (AHF) from erythrocytes of essential hypertensive human subjects on the systolic blood pressure (SBP) and diastolic blood pressure (DBP) in spontaneously hypertensive rats (SHR), renal hypertensive rats (RHR), Wistar-Kyoto rats (WKY) and Wistar rats were examined. Single intraperitoneal injection of AHF (1.6 mg/kg body weight) resulted in a significant decrease in SBP of SHR and RHR. At 10 min postinjection, AHF lowered the SBP in SHR by 34.0 mmHg. SBP recovered to the original level at 3 h. The maximal decrease of SBP in RHR by 92.5 mmHg was at 24h postadministration and the SBP did not recover until the 9th day. When AHF was administered via femoral vein (0.8 mg/kg body weight), the maximal decrease values of the SBP and the DBP were 42.8 and 48.2 mmHg in SHR at 12 min and 38.3 and 42.5 mmHg in RHR at 25 min postinjection respectively. The DBP in Wistar rats decreased considerably (from 96.7 +/- 12.9 to 83.3 +/- 11.7 mmHg) at 5 min postadministration of AHF, but no effect on DBP in WKY rats was observed. The depressor effect of AHF on SBP in RHR was dose-dependent. AHF could also antagonize the pressor effect of norepinephrine in Wistar rats.lld:pubmed
pubmed-article:1754902pubmed:languagechilld:pubmed
pubmed-article:1754902pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1754902pubmed:citationSubsetIMlld:pubmed
pubmed-article:1754902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1754902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1754902pubmed:statusMEDLINElld:pubmed
pubmed-article:1754902pubmed:monthAuglld:pubmed
pubmed-article:1754902pubmed:issn0371-0874lld:pubmed
pubmed-article:1754902pubmed:authorpubmed-author:BeyHHlld:pubmed
pubmed-article:1754902pubmed:authorpubmed-author:KUOM JMJlld:pubmed
pubmed-article:1754902pubmed:authorpubmed-author:ZhangS FSFlld:pubmed
pubmed-article:1754902pubmed:authorpubmed-author:ChenM QMQlld:pubmed
pubmed-article:1754902pubmed:authorpubmed-author:ZhouL PLPlld:pubmed
pubmed-article:1754902pubmed:issnTypePrintlld:pubmed
pubmed-article:1754902pubmed:volume43lld:pubmed
pubmed-article:1754902pubmed:ownerNLMlld:pubmed
pubmed-article:1754902pubmed:authorsCompleteYlld:pubmed
pubmed-article:1754902pubmed:pagination352-9lld:pubmed
pubmed-article:1754902pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:meshHeadingpubmed-meshheading:1754902-...lld:pubmed
pubmed-article:1754902pubmed:year1991lld:pubmed
pubmed-article:1754902pubmed:articleTitle[Effects of antihypertensive factor from erythrocytes of essential hypertensive subjects on blood pressure in rats].lld:pubmed
pubmed-article:1754902pubmed:affiliationDepartment of Physiology, Chinese Academy of Medical Sciences, Beijing.lld:pubmed
pubmed-article:1754902pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1754902pubmed:publicationTypeEnglish Abstractlld:pubmed